Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 741-746

  Inga, Alberto ^a   Scott, Gina ^b   Monti, Paola ^a   Aprile, Anna ^a   Abbondandolo, Angelo ^a,c   Burns, Philip A ^b   Fronza, Gilberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; LOMUSTINE; PROTEIN P53; PYRIMIDINE;

ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; FUNGUS MUTANT; GENE MUTATION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; RADIATION MUTAGENESIS; SKIN CANCER; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; YEAST;

DNA, COMPLEMENTARY; GENES, P53; HUMANS; MELANOMA; MUTATION; NEOPLASMS, RADIATION-INDUCED; SACCHAROMYCES CEREVISIAE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031844522     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.741     Document Type: Article

References (33)

1. 1.IARC (1992) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 55. IARC, Lyon, France.
2. Parkin,D.M., Muir,C.S., Whelan,S.L., Gao,Y.-T., Feraly,J. and Powel,J. (eds) (1992) Cancer Incidence in Five Continents, no. 120. IARC, Lyon, France.
3. Brash,D.E., Rudolph,J.A., Simon,J.A., Lin,A., McKenna,G.J., Baden,H.P., Halperin,A.J. and Ponten, J. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA, 88, 10124-10128.
4. Pierceall,W.E., Mukhopadhyay,T., Goldberg,L.H. and Ananthaswarmy, H.N. (1991) Mutations in the p53 tumour suppressor gene in human cutaneous squamous cell carcinomas. Mol. Carcinogenesis, 4, 445-449.
5. Rady,P., Scinicariello,F., Wagner,R.F.Jr and Tyring,S.K. (1992) p53 mutations in basal cell carcinomas. Cancer Res., 52, 3804-3806.
6. Matzumura,Y., Nishigori,C., Yagi,T., Imamura,S. and Takebe,H. (1996) Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas. Int. J. Cancer, 65, 778-780.
7. D'Errico,M., Calcagnile,A.S., Corona,R., Fucci,M., Annessi,G., Baliva,G., Tosti,M.E., Pasquini,P. and Dogliotti,E. (1997) p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res., 57, 747-752.
8. Ziegler,A., Leffell,D.J., Kunala,S. et al. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancer. Proc. Natl Acad. Sci. USA, 90, 4216-4220.
9. Ziegler,A., Jonason,A.S., Leffell,D.J., Simon,J.A., Sharma,H.W., Kimmelman,J., Remington,L., Sacks,T. and Brash,D.E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.
10. Nakazawa,H., English,D., Randell,P.L., Nakazawa,K., Martel,N., Amstrong,B.K. and Yamasaki,H. (1994) UV and skin cancer: specific p53 gene mutations in normal skin as a biologically relevant exposure measurement. Proc. Natl Acad. Sci. USA, 91, 360-364.
11. Jonason,A.S., Kunala,S., Price,G.J., Restifo,R.J., Spinelli,H.M., Persing,J.A., Leffell,D.J., Tarone,R.E. and Brash,D.E. (1996) Frequent clones of p53 mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA, 93, 14025-14029.
12. Miller,J.H. (1985) Mutagenic specificity of ultraviolet light. J. Mol. Biol., 182, 45-68.
13. Bredberg,A., Kraemer,K.H. and Seidman,M.M. (1986) Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc. Natl Acad. Sci. USA, 83, 8273-8277.
14. Drobetsky,E.A.. Grovosky,A.J. and Glickman,B.W. (1987) The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc. Natl Acad. Sci. USA, 84, 9103-9107.
15. McGregor,W.G., Chen,R.H., Lubash,L., Maher,V.M. and McCormick,J.J . (1991) Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair deficient cells. Mol. Cell Biol., 11, 1927-1934.
16. Inga,A., Iannone,R., Monti,P, Molina,F, Bolognesi,M., Abbondandolo,A., Iggo,R. and Fronza,G. (1997) Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene, 14, 1307-1313.
17. Flaman,J.M., Frebourg,T., Moreau,V. et al. (1995) A simple p53 functional assay for screening cell lines, blood, and tumours. Proc. Natl Acad. Sci. USA. 92, 3963-3967.
18. Hollstein,M., Shomer,B., Greenblatt,M., Soussi,T., Hovig,E., Montesano,R. and Harris,C.C. (1996) Somatic point mutation in the p53 gene of human tumours and cell lines updated compilation. Nucleic Acids Res., 24, 141-146.
19. Ishioka,C., Frebourg,T., Yan,Y.-X., Vidal,M., Friend,S.H., Schmidt,S. and Iggo,R. (1993) Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nature Genet., 5, 124-129.
20. Guthrie,C. and Fink,G.R. (1991) Methods in Enzymology, no. 194. Academic Press, San Diego.
21. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppression gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
22. Cariello,N.E, Piegorsch,W.W., Adams,W.T and Skopek,T.R. (1994) Computer programme for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis, 15, 2281-2285.
23. Ory,K., Legros,Y., Auguin,C. and Soussi,T. (1994) Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J., 13, 3496-3504.
24. Pietenpol,J.A., Tokino,T., Thiagalingam,S., El-Deiry,W.S., Kinzler,K.W. and Vogelstein,B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl Acad. Sci. USA, 91, 1998-2002.
25. Inga,A., Iannone,R., Campomenosi,P., Molina.F., Menichini,P., Abbondandolo,A. and Fronza,G. (1995) Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells. Cancer Res., 55, 4658-4663.
26. Tornaletti,S., Rozek,D. and Pfeifer,G.P. (1993) The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene, 8, 2051-2057.
27. Tornaletti,S. and Pfeifer,G.P. (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10, 1493-1499.
28. Bird,A. (1992) The essentials of DNA methylation. Cell, 70, 5-8.
29. Inga,A., Cresta,S., Monti,P., Aprile,A., Scott,G., Abbondandolo,A., Iggo,R. and Fronza,G. (1997) Simple identification of dominant p53 mutants by a yeast functional assay. Carcinogenesis, 10, 2019-2021.
30. Moshinsky,D. and Wogan,G.N. (1997) UV-induced mutagenesis of human p53 in a vector replicated in S.cerevisiae. Proc. Natl Acad. Sci. USA, 94, 2266-2271.
31. Vogelstein,B. and Kinzler,K.W. (1992) Carcinogens leave fingerprints. Nature, 355, 209-210.
32. Dogliotti,E. (1996) Mutational spectra: from model systems to cancer related genes. Carcinogenesis, 17, 2113-2118.
33. Harris,C.C. (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-1981.